Free Trial

Millennium Management LLC Buys Shares of 6,727 Nutex Health Inc. (NASDAQ:NUTX)

Nutex Health logo with Medical background

Millennium Management LLC bought a new position in shares of Nutex Health Inc. (NASDAQ:NUTX - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 6,727 shares of the company's stock, valued at approximately $213,000. Millennium Management LLC owned approximately 0.12% of Nutex Health as of its most recent SEC filing.

Several other institutional investors and hedge funds have also bought and sold shares of NUTX. Legato Capital Management LLC raised its holdings in Nutex Health by 26.8% during the fourth quarter. Legato Capital Management LLC now owns 31,669 shares of the company's stock worth $1,004,000 after buying an additional 6,697 shares during the last quarter. Truist Financial Corp increased its holdings in Nutex Health by 22.2% during the fourth quarter. Truist Financial Corp now owns 35,570 shares of the company's stock worth $1,127,000 after buying an additional 6,454 shares during the last quarter. Essex Investment Management Co. LLC increased its holdings in Nutex Health by 45.4% during the fourth quarter. Essex Investment Management Co. LLC now owns 105,809 shares of the company's stock worth $3,353,000 after buying an additional 33,024 shares during the last quarter. American Century Companies Inc. bought a new position in Nutex Health during the fourth quarter worth about $1,362,000. Finally, Geode Capital Management LLC boosted its position in Nutex Health by 12.6% during the fourth quarter. Geode Capital Management LLC now owns 34,125 shares of the company's stock worth $1,082,000 after purchasing an additional 3,826 shares during the period. 5.32% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of equities analysts have recently commented on the stock. Wall Street Zen lowered shares of Nutex Health from a "strong-buy" rating to a "buy" rating in a research report on Thursday, May 22nd. Benchmark boosted their price objective on shares of Nutex Health from $150.00 to $300.00 and gave the stock a "buy" rating in a report on Thursday, May 15th. Finally, Maxim Group lifted their target price on shares of Nutex Health from $100.00 to $225.00 and gave the stock a "buy" rating in a research note on Tuesday, May 20th.

Get Our Latest Stock Analysis on Nutex Health

Insider Transactions at Nutex Health

In other news, CFO Jon Christian Bates purchased 1,000 shares of the company's stock in a transaction that occurred on Tuesday, April 8th. The shares were bought at an average price of $81.81 per share, for a total transaction of $81,810.00. Following the purchase, the chief financial officer now directly owns 4,888 shares in the company, valued at approximately $399,887.28. This trade represents a 25.72% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 36.92% of the company's stock.

Nutex Health Trading Down 2.1%

Nutex Health stock traded down $2.65 during mid-day trading on Friday, reaching $122.28. 85,661 shares of the company traded hands, compared to its average volume of 76,267. The company has a debt-to-equity ratio of 3.36, a current ratio of 1.77 and a quick ratio of 1.74. The firm's 50 day moving average price is $137.12 and its 200 day moving average price is $77.90. The firm has a market capitalization of $679.27 million, a price-to-earnings ratio of -13.03 and a beta of 0.04. Nutex Health Inc. has a 52-week low of $4.16 and a 52-week high of $184.28.

Nutex Health (NASDAQ:NUTX - Get Free Report) last released its earnings results on Tuesday, May 13th. The company reported $2.56 earnings per share for the quarter, topping analysts' consensus estimates of ($0.15) by $2.71. The firm had revenue of $211.79 million for the quarter, compared to the consensus estimate of $81.09 million. Nutex Health had a negative net margin of 14.09% and a negative return on equity of 51.27%.

About Nutex Health

(Free Report)

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.

Recommended Stories

Institutional Ownership by Quarter for Nutex Health (NASDAQ:NUTX)

Should You Invest $1,000 in Nutex Health Right Now?

Before you consider Nutex Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutex Health wasn't on the list.

While Nutex Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Triple-Digit Gains: These 4 Nuclear Stocks Have Even More Upside Ahead
3 Made in America Stocks Under $20 You Need to See!
3 Cheap Growth Stocks Set to Explode This Summer

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines